Bifidobacterium Longum - Gut Health Ally

Bifidobacterium Longum is a beneficial bacteria that supports a healthy gut microbiome.

Bifidobacterium Longum FAQ

What is Bifidobacterium longum?

Bifidobacterium longum (B. longum) is a type of probiotic ("good" bacteria) that lives in the intestines. It produces lactic and acetic acid in the gut. "Good" bacteria such as B. longum can help break down food, absorb nutrients, and fight off "bad" organisms that might cause diseases.

What is Bifidobacterium longum good for?

The gut microbe B. longum may improve the human immune response and help prevent gut disorders. Early evidence suggests that it may also suppress allergies, reduce cholesterol, and improve skin health. Learn more here. What is Bifidobacterium longum?

Where does Bifidobacterium live?

The genus Bifidobacterium inhabits intestinal tracts of humans and animals. It is one of the first microorganisms to colonize the host gut [ 12 ]. It has more than 50 different species, of which, Bifidobacterium longum is one of the most abundant microorganisms in the intestines of infants and adults [ 8, 9 ].

Does Bifidobacterium longum colonize the human intestine?

Diseases inside and outside the intestine are closely related to the changes in the abundance of Bifidobacterium longum. Compared with healthy people, the abundance of Bifidobacterium longum flora in the stool of patients with intestinal diseases is much lower [ 14 ]. Bifidobacterium can be stably colonized in the human intestine.

How many species of Bifidobacterium are there?

In 2002, three previously distinct species of Bifidobacterium, B. infantis, B. longum, and B. suis, were unified into a single species named B. longum with the biotypes infantis, longum, and suis, respectively. This occurred as the three species had extensive DNA similarity including a 16S rRNA gene sequence similarity greater than 97%.

Does Bifidobacterium longum spp infantis 35624 survive?

Bifidobacterium longum spp. infantis 35624, originally isolated from the ileal mucosa of an individual free of gastrointestinal disease has been shown to survive transit through the gastrointestinal tract and to exert potent antiinflammatory effects in vivo in animal models.